The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells'. Together they form a unique fingerprint.
Biochemistry, Genetics and Molecular Biology
Neuroscience
Pharmacology, Toxicology and Pharmaceutical Science